Copyright © 2003 by the European Society of Cardiology.
Editorial
A paradigm shift in treatment for atrial fibrillation: from electrical to structural therapy?
University Hospital Gasthuisberg, Leuven, Belgium
* Correspondence to: Department of Cardiology, University Hospital Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium. Tel: +32 16 343 469; fax: +32 16 343 240
E-mail address: hein.heidbuchel@eurheartj.org
Received 16 June 2003; accepted 30 June 2003
| The first 10% of the full text of this article appears below. |
See doi:10.1016/j.ehj.2003.08.014for the article to which this editorial refers
Atrial fibrillation (AF) is associated with increased morbidity and mortality, most notably due to stroke and heart failure. Maintaining sinus rhythm in AF patients is not an easy task, and eventually it will even fail in most leading to permanent AF. Therefore, the therapeutic goal often lies in postponing permanent AF as long as possible. Except from the surgical correction of mitral valve disease, almost all therapeutic approaches have been focused on the electrical problem that is AF. The tools to maintain sinus rhythm, however, are suboptimal, leading to frustration at both the side of the patient and the doctor. Anti-arrhythmic drugs prevent multiple electrical wavelets by interfering with electrical
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in EHJ:
- Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation: Results of a prospective and controlled study
- Kwo-Chang Ueng, Tsung-Po Tsai, Wen-Chung Yu, Chin-Feng Tsai, Ming-Cheng Lin, Kuei-Chuan Chan, Chung-Yin Chen, Der-Jinn Wu, Chung-Sheng Lin, and Shih-Ann Chen
EHJ 2003 24: 2090-2098.[Abstract] [FREE Full Text]
This article has been cited by other articles:
![]() |
A. H Madrid, I. M. Marin, C. Escobar Cervantes, E. Bernal Morell, J. Escudero Estevez, G. Moreno, J. Rondon Parajon, Jian Peng, L. Limon, S. Nannini, et al. Prevention of recurrences in patients with lone atrial fibrillation. The dose-dependent effect of angiotensin II receptor blockers Journal of Renin-Angiotensin-Aldosterone System, September 1, 2004; 5(3): 114 - 120. [Abstract] [PDF] |
||||
![]() |
P. L. L'Allier, A. Ducharme, P.-F. Keller, H. Yu, M.-C. Guertin, and J.-C. Tardif Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation J. Am. Coll. Cardiol., July 7, 2004; 44(1): 159 - 164. [Abstract] [Full Text] [PDF] |
||||

